Acadia Healthcare Company, Inc. (ACHC) is a publicly traded Healthcare sector company. As of May 21, 2026, ACHC trades at $24.07 with a market cap of $2.33B and a P/E ratio of -2.01. ACHC moved -3.39% today. Year to date, ACHC is +68.56%; over the trailing twelve months it is -4.48%. Its 52-week range spans $11.43 to $64.89. Analyst consensus is buy with an average price target of $28.23. Rallies surfaces ACHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ACHC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ACHC recently traded at $24.07. Market cap is $2.33B. P/E ratio is -2.01. Revenue is $3.31B.
| Metric | Value |
|---|---|
| Price | $24.07 |
| Market Cap | $2.33B |
| P/E Ratio | -2.01 |
| EPS | $-12.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $64.89 |
| 52-Week Low | $11.43 |
| Volume | 1.25M |
| Avg Volume | 0 |
| Revenue (TTM) | $3.31B |
| Net Income | $-1.09B |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.31B | $-1.09B | $-12.16 |
| 2023 | $2.93B | $-15.66M | $-0.24 |
| 2022 | $2.61B | $280.03M | $3.05 |
| 2021 | $2.31B | $195.56M | $2.15 |
11 analysts cover ACHC: 0 strong buy, 6 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $28.23.